News
IGM Financial Inc. ( TSE:IGM ) has announced that it will pay a dividend of CA$0.5625 per share on the 31st of ...
Sales started to slow in the spring, as market uncertainty began to weigh on investor confidence, says CEO James O’Sullivan ...
Sanofi has scrapped its collaboration with IGM Biosciences, eliminating the biotech’s l | Sanofi has scrapped its ...
Shares Expanded Tech Sector has seen a significant rebound but remains fairly valued with a mixed technical outlook. Learn more about IGM ETF here.
After losing its powerhouse partner, IGM Biosciences closed “most” of its labs and offices and initiated a strategic review ...
US biotech IGM Biosciences (Nasdaq: IGMS), which is developing and delivering medicines to treat patients with autoimmune and ...
Power Corporation of Canada (Power Corporation or the Corporation) (TSX: POW) (TSX: POW.PR.E) today reported earnings results for the three months ended March 31, 2025.
10h
Zacks Investment Research on MSNIGM Biosciences, Inc. (IGMS) Reports Q1 Loss, Misses Revenue EstimatesIGM Biosciences, Inc. (IGMS) came out with a quarterly loss of $0.86 per share versus the Zacks Consensus Estimate of a loss of $0.41. This compares to loss of $0.83 per share a year ago. These ...
IGM Financial Inc. reported adjusted net earnings of $237.8 million for the first quarter, up 5.9% from the same quarter of ...
2d
News Medical on MSNSniffing Out the Flu: How a Supercharged Nasal Antibody Shields Against Viral AmbushScientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results